Adela M. Ciobanu, MD
Department of Neuroscience, Discipline of Psychiatry, University of Medicine and Pharmacy “Carol Davila,” Bucharest, Romania
Original Research
Add-on Pramipexole for Schizophrenia
August 1, 2022
Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...